# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...
Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by th...
Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.44) by...
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.